All CIRM Grants

Search Filters »

Institution Researcher name Grant Type Grant Title Award Value
The Regents of the University of California on behalf of its Riverside Campus Xiaoping Hu Conference II 19th Annual UC System-wide Bioengineering Symposium $14,536
Stanford University Dr. Joseph C. Wu Conference II 2018 Stanford Drug Discovery and Stem Cell Technology Conference $15,000
International Society for Stem Cell Research Cathy Vijeh CMP Conference II ISSCR 2019 $50,000
International Society for Stem Cell Research Ms. Glori Rosenson Conference II ISSCR 2019 Nucleus Forum $24,000
University of California, San Francisco David H Rowitch Conference II “Myelin Through the Ages: Evolution, Development, Degeneration and Disease” – 2018 Gordon Research Conference (GRC) and Gordon Research Seminar (GRS) $10,000
Keystone Symposia on Molecular and Cellular Biology Thale Jarvis Conference II iPSCs: A Decade of Progress and Beyond $35,000
Alliance Forum Foundation George Hara Conference II 2017 World Alliance Forum in San Francisco (WAFSF) “Healthcare Game Changers” $5,000
University of California, Irvine Dr. Leslie M Thompson Conference II Stem Cells for Huntington’s Disease (HD) International (SC4HDI) Conference $31,727
RUNX1 Research Program Timothy Babich Conference II Living with and Curing RUNX1 FPD/AML Forum $9,500
University of California, Los Angeles Song Li Conference II The 18th Annual UC System-Wide Bioengineering Symposium $25,000
JDRF International JDRF Esther Latres Conference II JDRF Encapsulation Consortium Fall 2017 Meeting $42,425
Stanford University Dr. Samuel Strober Conference II Third International Workshop on Clinical Tolerance $29,500
American Association of Blood Banks Dr. Naynesh R. Kamani Conference II 15th International Cord Blood Sympsium $30,000
Stanford University Dr. Joseph C. Wu Conference II 2017 Stanford Drug Discovery and Stem Cell Technology Conference $2,359
University of Southern California Dr. Justin K Ichida Conference II The 7th Annual California ALS research network and PAC10 meeting $10,830
Vitalant Research Institute Shibani Pati Conference II Cellular Therapies and Transfusion Medicine in Trauma and Critical Care – Looking Towards the Future $30,000
University of California, San Diego Dr. Robert Lie-Yuan Sah Conference II 2016 Tissue Engineering and Regenerative Medicine International Society – Americas (TERMIS-AM) Conference in San Diego, CA on December 11-14, 2016 $40,000
Midwinter Conference of Immunologists Dr. Christel H. Uittenbogaart Conference II The 2017 Midwinter Conference of Immunologists at Asilomar $5,000
Alliance Forum Foundation George Hara Conference II 2016 World Alliance Forum in San Francisco (WAFSF) “US-Japan Innovative Healthcare Technologies Conference” $20,000
University of California, Irvine Dr. LESLIE M Thompson Conference II HD-CARE INAUGURAL SYMPOSIUM $1,500
Keystone Symposia on Molecular and Cellular Biology Thale Jarvis Conference II Neurogenesis during Development and in the Adult Brain (joint with Transcriptional and Epigenetic Control in Stem Cells) $35,000
American Association of Blood Banks Dr. Naynesh R. Kamani Conference II 14th International Cord Blood Symposium: Give Life Twice $15,000
University of California, San Diego Prof. John M. Ravits Conference II California ALS Research Summit 2016 $11,400
Stanford University Dr. Joseph C. Wu Conference II Drug Discovery & Stem Cell Models for Cardiovascular Disease Conference $7,500
Gordon Research Conferences Dr. Ophir Klein MD, PhD Conference II 2016 Gordon Research Conference on Craniofacial Morphogenesis and Tissue Regeneration $5,000
City of Hope, Beckman Research Institute Fouad Kandeel Conference II 2016 Rachmiel Levine-Arthur Riggs Diabetes Research Symposium $10,000
International Society for Experimental Hematology Dr. David Traver Conference II International Society for Experimental Hematology, 45th Annual Scientific Meeting $25,000
University of California, Los Angeles Dr. Donald B. Kohn Conference II Primary Immune Deficiency Treatment Consortium (PIDTC) Annual Scientific Workshop $29,807
Alliance Forum Foundation George Hara Conference II 2015 World Alliance Forum in San Francisco (2015 WAFSF) “Regenerative Medicine: Let’s Talk Business!” $10,000
Sanford Consortium for Regenerative Medicine Dr. Edward Holmes Conference II Stem Cell Meeting on the Mesa $50,000
University of California, Irvine Dr. Sidney Golub Conference II Human Research In Times of Controversy: From Stem Cells To Fetal Tissue $13,562
Fate Therapeutics, Inc. Barbara Hickingbottom Clinical Trial Stage Projects A Phase 1 Study of FT819 in Participants with Moderate to Severe Active Systemic Lupus Erythematosus $7,934,448
ImmPACT-Bio, Inc. DR Jonathan Benjamin Clinical Trial Stage Projects A phase 1/2 study to evaluate a bispecific CD19/CD20-directed CAR T cell, in refractory lupus nephritis and systemic lupus erythematosus $8,000,000
University of California, San Francisco Dr. Hideho Okada Clinical Trial Stage Projects Phase 1 Study of Autologous E-SYNC T Cells in Adult Participants with EGFRvIII+ Glioblastoma $10,927,618
Aspen Neuroscience Dr. Edward Wirth III Clinical Trial Stage Projects Phase 1/2a Dose Escalation Study of ANPD001 in Sporadic Parkinson Disease $8,000,000
Alto Neuroscience Amit Etkin Clinical Trial Stage Projects A Phase 2b Study of the Efficacy of a Novel Pro-Neurogenesis/Pro-Plasticity Drug for Bipolar Depression Using a Precision Psychiatry Approach $15,000,000
Allogene Therapeutics Dr. John Le Gall Clinical Trial Stage Projects A PHASE 1B STUDY EVALUATING THE SAFETY AND EFFICACY OF AN ALLOGENEIC CELL THERAPY IN SUBJECTS WITH CLEAR CELL RENAL CELL CARCINOMA (ccRCC) $15,000,000
University of California, San Francisco Noriyuki Kasahara Clinical Trial Stage Projects A Phase I/IIa Study to Evaluate the Efficacy of Toca 511/Toca FC with Standard of Care Therapy in Newly Diagnosed High Grade Glioma $11,807,220
Luxa Biotechnology Dr. Jeffrey H Stern Clinical Trial Stage Projects RPESC-RPE-4W Therapy for dry Age-related Macular Degeneration $4,009,675
University of California, Davis Dr. Diana L. Farmer Clinical Trial Stage Projects The CuRe Trial: Cellular Therapy for In Utero Repair of Myelomeningocele $8,996,477
Stanford University Dr. Reena Parada Thomas Clinical Trial Stage Projects Phase I Trial of Locoregionally Delivered Autologous B7-H3 CAR T Cells (B7-H3CART) in Adults with Recurrent Glioblastoma Multiforme $11,999,991
City of Hope, Beckman Research Institute Elizabeth Budde Clinical Trial Stage Projects Phase I Study of Chimeric Antigen Receptor Engineered T Cells targeting CD33 for the Treatment of Relapsed/Refractory Acute Myeloid Leukemia $11,983,547
University of California, San Diego Prof. Olivia Kim-McManus Clinical Trial Stage Projects Personalized antisense oligonucleotide therapy for rare pediatric genetic disease: SCN2A $960,713
Stanford University Anusha Kalbasi Clinical Trial Stage Projects Stem-Derived IL13Ra2 Chimeric Antigen Receptor T cells for Patients with Melanoma and Advanced Solid Tumors $10,211,085
Regenerative Patch Technologies LLC Dr Jane S Lebkowski Clinical Trial Stage Projects A Phase 2b, Randomized, Assessor-Masked Clinical Trial to Assess the Safety and Efficacy of the CPCB-RPE1 Implant in Subjects with Geographic Atrophy $12,373,748
City of Hope, Beckman Research Institute Dr. Angelo Manuel Almeida Cardoso Ph.D., MD Clinical Trial Stage Projects Evaluation of Safety and Feasibility of Cytomegalovirus-Specific, Anti-HIV Chimeric Antigen Receptor (CMV/HIV-CAR) T Cells in People with HIV $11,299,976
Combangio, Inc. R. Kim Brazzell Clinical Trial Stage Projects Phase 2b Clinical Study of KPI-012 Topical Ophthalmic Human Mesenchymal Stem Cell Secretome for the Treatment of Persistent Corneal Epithelial Defect $15,000,000
Immusoft Corporation Dr Robert Hayes Clinical Trial Stage Projects A Phase I Open Label Study to Evaluate the Safety and Tolerability of ISP-001 in Patients with Mucopolysaccharidosis Type 1 $8,000,000
Eureka Therapeutics, Inc. Pei Wang Clinical Trial Stage Projects Autologous ARTEMIS® T Cells to Treat Refractory/Relapsed Pediatric Liver Cancer $10,600,072
Stanford University Dr. Matthew H Porteus Clinical Trial Stage Projects Reduced intensity conditioning with JSP191 prior to TCRαβ+ T-cell/CD19+ B-cell depleted hematopoietic stem cell transplant for Fanconi Anemia patients $10,642,420
1 … 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29